Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Journal of Hematology & Oncology|September 6, 2022
ASXL1/2 mutations and myeloid malignanciesEdward A Medina, Caroline R Delma, Feng-Chun YangLeukemia|January 26, 2026
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in miceYing Guo, Pinpin Sui, Hui Yang, et al.The Journal of Clinical Investigation|November 2, 2023
Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical modelsGuo Ge, Peng Zhang, Pinpin Sui, et al.EMBO Reports|August 31, 2023
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clippingHui Yang, Pinpin Sui, Ying Guo, et al.Leukemia|November 17, 2025
Oncogenic activation of EVC/EVC2 defines a therapeutically targetable subset of acute myeloid leukemiaPinpin Sui, Ying Li, Juyeong Hong, et al.Plos One|April 25, 2013
Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algaeSheeja Aravindan, Caroline R Delma, Somasundaram S Thirugnanasambandan, et al.Carcinogenesis|December 4, 2018
Heterozygous Tsc2 (Tsc2+/-) mouse model to study induced renal cancer in response to ionizing radiation at low dosesSureshkumar M A, Caroline R Delma, Krishnan Manickam, et al.International Journal of Biological Macromolecules|December 27, 2014
Fucoidan from Turbinaria conoides: a multifaceted 'deliverable' to combat pancreatic cancer progressionCaroline R Delma, Somasundaram T Somasundaram, Guru Prasad Srinivasan, et al.Phytochemistry|August 27, 2019
Fucoidan from marine brown algae attenuates pancreatic cancer progression by regulating p53 - NFκB crosstalkCaroline R Delma, Somasundaram Thirugnanasambandan, Guru Prasad Srinivasan, et al.International Journal of Hematology|April 16, 2023
Epigenetic regulation by ASXL1 in myeloid malignanciesFeng-Chun Yang, Joel Agosto-PeñaPageof 14